Universe Pharmaceuticals Stock Market Value
| UPC Stock | USD 3.98 0.41 9.34% |
| Symbol | Universe |
Will Biotechnology sector continue expanding? Could Universe diversify its offerings? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Universe Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.82) | Earnings Share (8.06) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Universe Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Universe Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Universe Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Universe Pharmaceuticals.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Universe Pharmaceuticals on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Universe Pharmaceuticals or generate 0.0% return on investment in Universe Pharmaceuticals over 90 days. Universe Pharmaceuticals is related to or competes with Painreform, Elevai Labs, Bluejay Diagnostics, Tivic Health, Moolec Science, BriaCell Therapeutics, and Shuttle Pharmaceuticals. Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of... More
Universe Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Universe Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Universe Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 52.35 | |||
| Value At Risk | (8.79) | |||
| Potential Upside | 13.75 |
Universe Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Universe Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Universe Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Universe Pharmaceuticals historical prices to predict the future Universe Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0064 | |||
| Jensen Alpha | 0.0314 | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | 0.0398 |
Universe Pharmaceuticals February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0064 | |||
| Market Risk Adjusted Performance | 0.0498 | |||
| Mean Deviation | 4.57 | |||
| Coefficient Of Variation | (33,025) | |||
| Standard Deviation | 7.08 | |||
| Variance | 50.19 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | 0.0314 | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | 0.0398 | |||
| Maximum Drawdown | 52.35 | |||
| Value At Risk | (8.79) | |||
| Potential Upside | 13.75 | |||
| Skewness | 1.31 | |||
| Kurtosis | 5.98 |
Universe Pharmaceuticals Backtested Returns
Universe Pharmaceuticals appears to be very risky, given 3 months investment horizon. Universe Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0506, which indicates the firm had a 0.0506 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Universe Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Universe Pharmaceuticals' Risk Adjusted Performance of 0.0064, variance of 50.19, and Coefficient Of Variation of (33,025) to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Universe Pharmaceuticals holds a performance score of 4. The entity has a beta of -0.79, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Universe Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Universe Pharmaceuticals is likely to outperform the market. Please check Universe Pharmaceuticals' value at risk, as well as the relationship between the accumulation distribution and day typical price , to make a quick decision on whether Universe Pharmaceuticals' existing price patterns will revert.
Auto-correlation | -0.24 |
Weak reverse predictability
Universe Pharmaceuticals has weak reverse predictability. Overlapping area represents the amount of predictability between Universe Pharmaceuticals time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Universe Pharmaceuticals price movement. The serial correlation of -0.24 indicates that over 24.0% of current Universe Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:Check out Universe Pharmaceuticals Correlation, Universe Pharmaceuticals Volatility and Universe Pharmaceuticals Performance module to complement your research on Universe Pharmaceuticals. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Universe Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.